CB2 signs Colombian cannabis deal

34w
1m read
Summary

CB2 has entered into a partnership with FCM Global, the first Colombian cannabis company to be fully licensed to cultivate, manufacture and export low-THC cannabis extracts for research and clinical trials. EU to adopt Germany’s medical cannabis approach CB2, a Canadian medical cannabis-focused data firm, said it will look to blend its clinical operations with “technology, analytics clinical research expertise” to support FCM with market access, data collection and analysis, and drug discovery. In a statement, the Toronto-based company said the partnership will work to create market access and design clinical trials to support the deployment of future FCM cannabinoid-based products. FCM owns and operates a 235,800 sq ft production facility in La Ceja, Antioquia, as well as an expanded cultivation and biomass production facility of 474 hectares in Tolima.

Article Preview

CB2 has entered into a partnership with FCM Global, the first Colombian cannabis company to be fully licensed to cultivate, manufacture and export low-THC cannabis extracts for research and clinical trials.  

In a statement, the Toronto-based company said the partnership will work to create market access and design clinical trials to support the deployment of future FCM cannabinoid-based products

FCM owns and operates a 235,800 sq ft production facility in La Ceja, Antioquia, as well as an expanded cultivation and biomass production facility of 474...

Read the full article @ The Leaf Desk